cidofovir anhydrous has been researched along with Duncan Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, R; Espinoza, JL; Kuzushima, K; Nakao, S; Nishimura, R; Okumura, H; Takamatsu, H; Yachie, A; Yoshida, T | 1 |
| Fiedler, F; Hänel, M; Thorns, C | 1 |
2 other study(ies) available for cidofovir anhydrous and Duncan Disease
| Article | Year |
|---|---|
Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Cidofovir; Cytosine; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Leukemia, Lymphoid; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Organophosphonates; Rituximab; Transplantation, Homologous; Treatment Outcome | 2016 |
Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Cidofovir; Cytosine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphoid; Lymph Nodes; Lymphoproliferative Disorders; Meninges; Organophosphonates; Organophosphorus Compounds; Prognosis; Rituximab | 2001 |